INUS
Straddle Chart

Markets / Mutual funds / Sectoral / Thematic

Mutual fundsSIF

quant Healthcare Fund - Direct Plan - Growth

NAVs of 8 Nov 2026

quant Mutual Fund · Equity fund · Direct plan · Growth

Sectoral / ThematicDirect · GrowthRisk: Very High
NAV · 6 Nov 2026
₹19.0563 ▲ 0.76%
quant Mutual Fund
Fund size₹412 crJuly - September 2026
1-month range₹17.51 – 19.06
1 year+21.17%rank 13 of 204
Expense ratio1.57%direct plan, a year
5 years–a year

What the fund does

The investment objective of the scheme is to seek long term capital appreciation by investing in equity/equity related instruments of companies from the healthcare sector. There is no assurance that the investment objective of the Scheme will be achieved.

BenchmarkNifty Healthcare TRI
LaunchedInvalid Date
Fund housequant Mutual Fund

NAV history

181919 2026-08-122026-08-252026-09-072026-09-212026-10-052026-10-162026-10-30

Returns

1 week
+3.01%avg 5.2%
1 month
+2.18%avg 3.0%
3 months
+2.17%avg -1.6%
6 months
+12.40%avg 3.7%
This year
+22.25%avg 4.5%
1 year
+21.17%avg 5.5% · #13/204
3 years (a year)
+21.81%avg 15.3% · #14/127

Bars: this plan; the thin mark is the Sectoral / Thematic average (direct plans, growth option). Over a year: yearly averages (CAGR). Past returns do not guarantee future returns. Information only, not investment advice.

Monthly returns (%)

YearJanFebMarAprMayJunJulAugSepOctNovDec
2024-4.4
2025-3.7-11.7+7.0+3.1+6.3+1.6-0.9-4.3+2.0+2.0-0.3-2.0
2026-4.0+4.6-5.3+8.3+6.3+5.3+2.1+5.9-2.9-1.9+3.0

Each month's change in NAV (the current month to the latest NAV).

What if you had invested?

Worked out from this plan's actual NAVs. SIP: invested on the first NAV of each month. Taxes and exit loads are not included. Past returns do not guarantee future returns. Information only, not investment advice.

Portfolio as on 30 Oct 2026

Stocks held1227 lines in all
Top 10 stocks63.9%of the fund
Short positions-26.8%sold through derivatives
Net equity72.5%long stocks and derivatives minus shorts

Where the money is

Equity 66.4%Derivatives (long) 32.8%Money market 6.4%Short -26.8%

Sectors (stocks held)

Pharmaceuticals & Biotechnology
55.2%
Food Products
4.5%
Consumer Durables
3.3%
Personal Products
3.2%
Fertilizers & Agrochemicals
0.2%

Changes since 30 Sept 2026

Share of fund30 Oct 202630 Sept 2026Change
Stocks held66.4%67.3%-0.86
Short positions-26.8%-32.3%+5.50
Derivatives (long)32.8%32.1%+0.71
Money market6.4%6.3%+0.13
Cash & others-5.7%-5.7%+0.04
Top 10 stocks63.9%64.1%-0.21
Number of stocks1213-1
Stocks sold off 1
  • Natco Pharma Ltdwas 3.01%
Bought more 4
  • Aurobindo Pharma Limited+4.74
  • LG Electronics India Limited+2.75
  • Zydus Lifesciences Limited+0.87
  • Dr. Reddy's Laboratories Limited+0.27
Cut back 6
  • Alivus Life Sciences-3.88
  • Glaxosmithkline Pharmaceuticals Ltd-0.80
  • IPCA Laboratories Ltd-0.61
  • Zydus Wellness Ltd-0.39
  • Colgate-Palmolive (India) Ltd-0.27
  • Strides Pharma Science Limited-0.25

Change is in percentage points. Bought more and cut back list stocks whose share of the fund moved by at least 0.25 points. A share can also move because the price changed, not only because the fund traded.

Stocks held 12

HoldingSector / type% of fund
Zydus Lifesciences Limited
INE010B01027		Pharmaceuticals & Biotechnology10.25%
Aurobindo Pharma Limited
INE406A01037		Pharmaceuticals & Biotechnology9.83%
Glaxosmithkline Pharmaceuticals Ltd
INE159A01016		Pharmaceuticals & Biotechnology8.89%
Strides Pharma Science Limited
INE939A01011		Pharmaceuticals & Biotechnology8.79%
Pfizer Ltd
INE182A01018		Pharmaceuticals & Biotechnology7.14%
IPCA Laboratories Ltd
INE571A01038		Pharmaceuticals & Biotechnology5.37%
Zydus Wellness Ltd
INE768C01028		Food Products4.50%
LG Electronics India Limited
INE324D01010		Consumer Durables3.34%
Colgate-Palmolive (India) Ltd
INE259A01022		Personal Products3.18%
Dr. Reddy's Laboratories Limited
INE089A01031		Pharmaceuticals & Biotechnology2.61%
Alivus Life Sciences
INE03Q201024		Pharmaceuticals & Biotechnology2.34%
Sumitomo Chemical India Limited
INE258G01013		Fertilizers & Agrochemicals0.19%

Short positions 1

HoldingSector / type% of fund
NCA-NET CURRENT ASSETS–-26.80%

Derivatives, debt, money market and cash 14

HoldingSector / type% of fund
TREPS 02-Nov-2026 DEPO 10
INCBLO021126		–21.10%
Divi's Laboratories Ltd.
INE361B01024		Pharmaceuticals & Biotechnology9.92%
Glenmark Pharmaceuticals Ltd.
INE935A01035		Pharmaceuticals & Biotechnology9.38%
Torrent Pharmaceuticals Ltd.
INE685A01028		Pharmaceuticals & Biotechnology8.46%
Biocon Ltd.
INE376G01013		Pharmaceuticals & Biotechnology5.06%
91 Days Treasury Bill 05-Nov-2026
IN002026X180		–0.72%
91 Days Treasury Bill 19-Nov-2026
IN002026X206		–0.72%
91 Days Treasury Bill 27-Nov-2026
IN002026X214		–0.72%
91 Days Treasury Bill 03-Dec-2026
IN002026X222		–0.72%
91 Days Treasury Bill 10-Dec-2026
IN002026X230		–0.72%
91 Days Treasury Bill 17-Dec-2026
IN002026X248		–0.71%
91 Days Treasury Bill 24-Dec-2026
IN002026X255		–0.71%
91 Days Treasury Bill 14-Jan-2027
IN002026X289		–0.71%
91 Days Treasury Bill 28-Jan-2027
IN002026X305		–0.71%

From the fund house's monthly portfolio (quantmutual.com), as on 30 Oct 2026. Percentages are of the fund's net assets; short positions are negative. Published about ten days after each month ends.

Risk

Volatility16.3%yearly, from daily NAVs
Worst fall-24.59%13 Sept 2024 → 28 Feb 2025
RiskometerVery HighVery High

Volatility: how much the NAV moves, as a yearly figure (higher = bumpier). Worst fall: the biggest drop from a high, in the NAV history we hold (from 31 Jul 2023).

Where it can invest (limits from the scheme document)

Equity and Equity related instruments in Healthcare space
80–100%
Equity and equity related instruments other than Healthcare space
0–20%
Debt & Money Market instruments
0–20%
Units issued by InvITs
0–5%
Foreign securities including ADRs / GDRs / Foreign equity and debt securities and Overseas ETFs
0–20%

The ranges the fund is allowed to hold, not what it holds today.

Fund details

Fund size (average AUM, July - September 2026)₹412 cr across all plans · this plan ₹158 cr
Fund housequant Mutual Fund
CategoryEquity · Sectoral / Thematic
PlanDirect
OptionGrowth
Expense ratio (TER)Direct 1.57% · Regular 3.00% (6 Nov 2026)
Exit loadFor redemptions / switch outs (including SIP/STP) within 15 days from the date of allotment of units, irrespective of the amount of investment: 1% No exit load shall be applicable on switches from Regular Plan to Direct Plan and vice versa, under the same scheme.
Minimum investment₹5,000 · additional ₹1,000
Scheme code (AMFI)151853
ISININF966L01CD0
NAV date6 Nov 2026

Scheme details from the fund's scheme summary document filed with AMFI; expense ratios from AMFI's daily filings.

Other plans of this fund

PlanNAV1 year
Direct · IDCW₹19.0542+21.17%
Regular · Growth₹18.0553+19.24%
Regular · IDCW₹18.0543+19.24%

Top Sectoral / Thematic funds (direct plans)

Fund1 year3 years (a year)
Nippon India Taiwan Equity Fund+39.55%+42.38%
HDFC Defence Fund+20.78%+35.14%
HDFC Pharma and Healthcare Fund+28.23%+31.72%
SBI HEALTHCARE OPPORTUNITIES FUND+22.32%+25.68%
HDFC Transportation and Logistics Fund+9.94%+25.29%
Mirae Asset Healthcare Fund+24.35%+25.21%
UTI - Healthcare Fund+18.81%+24.71%
ICICI PRUDENTIAL TRANSPORTATION AND LOGISTICS FUND+11.93%+23.21%
quant Healthcare Fund+21.17%+21.81%

All Sectoral / Thematic funds ranked › · Compare with others ›

← All mutual funds

Information only, not investment advice.

What is the NAV of quant Healthcare Fund - Direct Plan - Growth today?

₹19.0563 as of 6 Nov 2026, from AMFI's official NAV data.

What are the returns of quant Healthcare Fund - Direct Plan - Growth?

1 year: 21.17%, 3 years: 21.81% a year

How does quant Healthcare Fund rank in its category?

13 of 204 Sectoral / Thematic funds (direct plans, growth option) by 1-year return.

What is the difference between direct and regular plans?

Both invest in the same portfolio. Direct plans are bought straight from the fund house and pay no distributor commission, so their expenses are lower and their NAV grows slightly faster.